anti-Thymidine Glycol [TG], mAb (2E8)
| Code | Size | Price |
|---|
| JAI-MTG-100P-100ug | 100 ug | £565.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Antibody Isotype: Mouse IgG1kappa
Antibody Clonality: Monoclonal
Antibody Clone: 2E8
Regulatory Status: RUO
Target Species: Human
Application: Immunohistochemistry (IHC)
Shipping:
BLUE ICE
Storage:
-20°C
Documents
Further Information
EClass:
32160000
Form (Short):
liquid
Formulation:
Lyophilized. Contains 10mM PBS, pH7.4 containing 1.0% BSA.
Handling Advice:
Avoid freeze/thaw cycles.
Immunogen:
Thymidine glycol polymer.
Long Description:
Monoclonal Antibody. Recognizes DNA containing thymidine glycol. Does not cross-react with oxidized dC polymer, oxidized dG polymer and oxidized dA polymer. Does not react with free thymidine glycol. Lyophilized. Contains 10mM PBS, pH7.4 containing 1.0% BSA. Thymidineglycol (TG) is one of the major oxidation products of DNA. Thymidine (T) can be damaged by oxidative stress such as radiation and energy metabolism. Two different pathways to form TG have been suggested. Deoxythymidine in DNA is directly oxidised by hydroxy radical, to form TG. TG can be also formed through an intermediate thymidine chlorohydrin, which is derived from hypochlorous acid (HOCl) from neutrophil myeloperoxidase. Thymidineglycol is derived from DNA, not from RNA. TG is the oxidative stress marker secific for DNA damage. In comparison with 8-hydroxy-2'-deoxyguanosine (8-OHdG), which is the best known DNA oxidation product it was shown that in a lipopolysaccharide (LPS)-treated mouse liver, 8-OHdG can be stained within 24 hours after LPS treatment. TG can be detected within 6 hours, and remains at least for 72 hours.
Package Type:
Plastic Vial
Product Description:
Thymidineglycol (TG) is one of the major oxidation products of DNA. Thymidine (T) can be damaged by oxidative stress such as radiation and energy metabolism. Two different pathways to form TG have been suggested. Deoxythymidine in DNA is directly oxidised by hydroxy radical, to form TG. TG can be also formed through an intermediate thymidine chlorohydrin, which is derived from hypochlorous acid (HOCl) from neutrophil myeloperoxidase. Thymidineglycol is derived from DNA, not from RNA. TG is the oxidative stress marker secific for DNA damage. In comparison with 8-hydroxy-2'-deoxyguanosine (8-OHdG), which is the best known DNA oxidation product it was shown that in a lipopolysaccharide (LPS)-treated mouse liver, 8-OHdG can be stained within 24 hours after LPS treatment. TG can be detected within 6 hours, and remains at least for 72 hours.
Specificity:
Recognizes DNA containing thymidine glycol. Does not cross-react with oxidized dC polymer, oxidized dG polymer and oxidized dA polymer. Does not react with free thymidine glycol.
Transportation:
Non-hazardous
UNSPSC Category:
Primary Antibodies
UNSPSC Number:
12352203
Use & Stability:
Stable for at least 3 years after receipt when stored at -20°C. After reconstitution, prepare aliquots and store at -20°C.
References
Serum antioxidant capacity and oxidative injury to pulmonary DNA in never-smokers with primary lung cancer: K. Ito, et al.; Anticancer Res. 32, 1063 (2012)
Related Products
| Product Name | Product Code | Supplier | anti-4-Hydroxy-2-nonenal [4-HNE], mAb (HNEJ-2) | JAI-MHN-020P | JaICA | Summary Details | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| anti-4-Hydroxy-2-nonenal [4-HNE], mAb (HNEJ-2) | JAI-MHN-100P | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| anti-7-Ketocholesterol [7-KC], mAb (35A) | JAI-MKC-020N | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| anti-Malondialdehyde [MDA], mAb (1F83) | JAI-MMD-030N | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| anti-Nitrotryptophan (NW), mAb (117C) | JAI-MNW-020P | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| anti-8-Hydroxy-2'-deoxyguanosine [8-OHdG], mAb (N45.1) | JAI-MOG-020P | JaICA | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||